Expression and mutations of BRCA in breast cancer and ovarian cancer: Evidence from bioinformatics analyses

  • Authors:
    • Zhu Wang
    • Jianwen Zhang
    • Ying Zhang
    • Qiong Deng
    • Hui Liang
  • View Affiliations

  • Published online on: September 11, 2018     https://doi.org/10.3892/ijmm.2018.3870
  • Pages: 3542-3550
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2) are the most well‑known genes linked to breast cancer and ovarian cancer, which are crucial in DNA repair and transcriptional regulation. The present study aimed to elucidate the expression profiles, mutations and interaction networks of BRCA1 and BRCA2, which may provide insights to reveal the mechanisms of BRCA genes ultimately leading to breast or ovarian tumorigenesis. Bioinformatics analyses were performed in the present study. The mRNA levels of BRCA1 and BRCA2 were evaluated using FIREHOSE analysis, SAGE Genie tools and Oncomine analysis. cBioPortal analysis, and Catalogue Of Somatic Mutations In Cancer analysis were used to examine the BRCA1 and BRCA2 mutations. Kaplan‑Meier Plotter analysis was performed to identify the prognostic roles of BRCA1 and BRCA2 in breast cancer and ovarian cancer. The results of the present study showed that the mRNA expression levels of BRCA1 and BRCA2 were elevated in breast cancer and ovarian cancer tissues, compared with their matched normal tissues. Second, several common mutations of BRCA1 and BRCA2 genes were identified in breast cancer and ovarian cancer. Finally, neurofibromin 1, synaptonemal complex protein 2 and tumor protein 53 were predicted to be involved in the interaction network of BRCA1 and BRCA2 in breast cancer and ovarian cancer. Taken together, these results provide a significant insight into certain mutations and proteins involved in the interaction network of BRCA1 and BRCA2, which may have common roles in breast cancer and ovarian cancer. However, the complex mechanism underlying these observations remains to be fully elucidated, and further investigations are required in the future.
View Figures
View References

Related Articles

Journal Cover

December-2018
Volume 42 Issue 6

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

The Cancer Story
Copy and paste a formatted citation
x
Spandidos Publications style
Wang Z, Zhang J, Zhang Y, Deng Q and Liang H: Expression and mutations of BRCA in breast cancer and ovarian cancer: Evidence from bioinformatics analyses. Int J Mol Med 42: 3542-3550, 2018
APA
Wang, Z., Zhang, J., Zhang, Y., Deng, Q., & Liang, H. (2018). Expression and mutations of BRCA in breast cancer and ovarian cancer: Evidence from bioinformatics analyses. International Journal of Molecular Medicine, 42, 3542-3550. https://doi.org/10.3892/ijmm.2018.3870
MLA
Wang, Z., Zhang, J., Zhang, Y., Deng, Q., Liang, H."Expression and mutations of BRCA in breast cancer and ovarian cancer: Evidence from bioinformatics analyses". International Journal of Molecular Medicine 42.6 (2018): 3542-3550.
Chicago
Wang, Z., Zhang, J., Zhang, Y., Deng, Q., Liang, H."Expression and mutations of BRCA in breast cancer and ovarian cancer: Evidence from bioinformatics analyses". International Journal of Molecular Medicine 42, no. 6 (2018): 3542-3550. https://doi.org/10.3892/ijmm.2018.3870